Search

M2 PRESSWIRE-February 16, 2023-: Dengue Fever Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-December 7, 2022-: Dengue Fever Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments (C)1994-2022 M2 COMMUNICATIONS RDATE:06122022 [...]

M2 PRESSWIRE-November 9, 2021-: Global Dengue Fever Clinical Trials Report, H2 2021: Phase, Trial Status, End Points Status and Sponsor Type Review (C)1994-2021 M2 COMMUNICATIONS RDATE:09112021 The 'Dengue Fever - [...]

M2 PRESSWIRE-June 18, 2021-: Worldwide Dengue Vaccine Industry to 2025 - Key Drivers, Challenges and Trends (C)1994-2021 M2 COMMUNICATIONS RDATE:18062021 The 'Global Dengue Vaccine Market 2021-2025' report has been added [...]

M2 PRESSWIRE-April 15, 2021-: Global Dengue Vaccines Disease Analysis Report 2021-2022: Approvals of TV003/TV005 and Domestic Vaccines will Lead to Considerable Competition (C)1994-2021 M2 COMMUNICATIONS RDATE:15042021 The 'Disease Analysis: Dengue [...]

M2 PRESSWIRE-June 24, 2014-: Global Dengue Fever Pipeline Report 2014-2017 (C)1994-2014 M2 COMMUNICATIONS RDATE:24062014 Dublin - Research and Markets (http://www.researchandmarkets.com/research/mh2fz3/dengue_fever) has announced the addition of the 'Dengue Fever Pipeline Highlights [...]

M2 PRESSWIRE-April 25, 2013-: Dengue Fever Pharma Deals Partnering Report 2007-2013(C)1994-2013 M2 COMMUNICATIONS RDATE:25042013 Dublin - Research and Markets has announced the addition of the Dengue Fever Partnering 2007-2013 report [...]